ASTELLAS PHARMA
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 2005-01-01
- Employees
- -
- Market Cap
- $22.5B
- Website
- https://www.astellas.com/
Study Using CP-461 to Treat Advanced Prostate Cancer
Phase 2
Completed
- Conditions
- Prostate Cancer
- First Posted Date
- 2002-05-08
- Last Posted Date
- 2011-10-17
- Lead Sponsor
- Astellas Pharma Inc
- Target Recruit Count
- 25
- Registration Number
- NCT00036075
- Locations
- 🇺🇸
Columbia Presbyterian Medical Center, New York, New York, United States
🇺🇸University of Washington, Seattle, Washington, United States
© Copyright 2025. All Rights Reserved by MedPath